Log in to save to my catalogue

The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein...

The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ff4a4f7438a460f8a91ec3fc7c58bc4

The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models

About this item

Full title

The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models

Publisher

England: The Company of Biologists Ltd

Journal title

Disease models & mechanisms, 2022-06, Vol.15 (6)

Language

English

Formats

Publication information

Publisher

England: The Company of Biologists Ltd

More information

Scope and Contents

Contents

Heterozygous mutations in the GBA1 gene - encoding lysosomal glucocerebrosidase (GCase) - are the most common genetic risk factors for Parkinson's disease (PD). Experimental evidence suggests a correlation between decreased GCase activity and accumulation of alpha-synuclein (aSyn). To enable a better understanding of the relationship between aSyn a...

Alternative Titles

Full title

The GBA1 D409V mutation exacerbates synuclein pathology to differing extents in two alpha-synuclein models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2ff4a4f7438a460f8a91ec3fc7c58bc4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2ff4a4f7438a460f8a91ec3fc7c58bc4

Other Identifiers

ISSN

1754-8403,1754-8411

E-ISSN

1754-8411

DOI

10.1242/dmm.049192

How to access this item